短期市場仍有下挫尋底風險

大市盤面:今日港股繼續縮量調整。恆指微漲0.20%,報24813點,大市成交額985億港元;國指微漲00.14%,報8806點;科技指數漲0.45%,報6221點。
板塊方面,大型科技股表現低迷,快手、京東跌超1%,美團、阿裏微跌,小米收平,騰訊微漲,B站漲1.83%。
醫藥外包概念反彈,藥明生物漲超10%,康龍化成漲近9%,泰格醫藥漲超5%,藥明康德漲4.33%。
半導體走強,上海復旦漲超16%,華虹半導體漲4.01%,中芯國際漲3.91%,ASM太平洋漲1.52%。
餐飲、非酒飲料、煤炭、電子零件等板塊表現低迷。
個股方面,藥明生物漲超10%,瑞信發佈研究報告,維持藥明生物“跑贏大市”評級,目標價151港元。
港股通方面,今日南向資金淨流出5.40億港元。今日北水淨賣出美團4.57億港元,騰訊控股2.74億港元,香港交易所1.25億港元;淨買入藥明生物1.45億港元,泡泡瑪特1.45億港元,中芯國際1.35億港元。
數據方面:今日港股嚴重縮量,恆指波幅指數溫度同步下挫;渦輪牛熊、恆指期權沽購比同步上揚,短期市場仍有下挫尋底風險。
本文數據及觀點僅供交流學習,不構成投資建議!投資有風險,入市需謹慎!
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.